Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
25,413,123
-
Shares change
-
+1,361,992
-
Total reported value, excl. options
-
$914,855,472
-
Value change
-
+$45,084,655
-
Put/Call ratio
-
44%
-
Number of buys
-
63
-
Number of sells
-
-63
-
Price
-
$36
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q1 2021
159 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q1 2021.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,413,123 shares
of 48,041,653 outstanding shares and own 52.9% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (7,440,107 shares), VANGUARD GROUP INC (1,406,031 shares), BlackRock Inc. (1,312,818 shares), MARSHALL WACE, LLP (1,176,033 shares), WASATCH ADVISORS INC (1,132,471 shares), GENEVA CAPITAL MANAGEMENT LLC (1,033,095 shares), Ranger Investment Management, L.P. (922,510 shares), AMERIPRISE FINANCIAL INC (917,781 shares), Russell Investments Group, Ltd. (651,249 shares), and BANK OF AMERICA CORP /DE/ (527,329 shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.